Ming-Hai Wang - Search Results

Year	Number of Results
2002	4
2003	2
2004	4
2005	2
2006	2
2007	3
2008	2
2010	7
2011	4
2012	7
2013	6
2014	8
2015	5
2016	3
2017	1
2018	2
2019	4
2020	10
2021	8
2022	0

1

RNA methyltransferase NSUN2 promotes gastric cancer cell proliferation by repressing p57^Kip2 by an m⁵C-dependent manner.

Mei L, Shen C, Miao R, Wang JZ, Cao MD, Zhang YS, Shi LH, Zhao GH, Wang MH, Wu LS, Wei JF. Mei L, et al. Among authors: wang mh. Cell Death Dis. 2020 Apr 24;11(4):270. doi: 10.1038/s41419-020-2487-z. Cell Death Dis. 2020. PMID: 32332707 Free PMC article.

2

Oncogenic mechanism-based pharmaceutical validation of therapeutics targeting MET receptor tyrosine kinase.

Yao HP, Tong XM, Wang MH. Yao HP, et al. Among authors: wang mh. Ther Adv Med Oncol. 2021 Apr 3;13:17588359211006957. doi: 10.1177/17588359211006957. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33868463 Free PMC article. Review.

3

MSP-RON signalling in cancer: pathogenesis and therapeutic potential.

Yao HP, Zhou YQ, Zhang R, Wang MH. Yao HP, et al. Among authors: wang mh. Nat Rev Cancer. 2013 Jul;13(7):466-81. doi: 10.1038/nrc3545. Nat Rev Cancer. 2013. PMID: 23792360 Review.

4

Duocarmycin-based antibody-drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy: Pharmaceutical strategy and clinical progress.

Yao HP, Zhao H, Hudson R, Tong XM, Wang MH. Yao HP, et al. Among authors: wang mh. Drug Discov Today. 2021 Aug;26(8):1857-1874. doi: 10.1016/j.drudis.2021.06.012. Epub 2021 Jul 3. Drug Discov Today. 2021. PMID: 34224904 Free article. Review.

5

Pharmaceutical strategies in the emerging era of antibody-based biotherapeutics for the treatment of cancers overexpressing MET receptor tyrosine kinase.

Yao HP, Tong XM, Wang MH. Yao HP, et al. Among authors: wang mh. Drug Discov Today. 2021 Jan;26(1):106-121. doi: 10.1016/j.drudis.2020.11.002. Epub 2020 Nov 7. Drug Discov Today. 2021. PMID: 33171292 Free article. Review.

6

IARS2 regulates proliferation, migration, and angiogenesis of human umbilical vein endothelial cells.

Yu YM, Xu L, Li HR, Zhang TQ, Qian G, Li LF, Wang MH. Yu YM, et al. Among authors: wang mh. Rev Assoc Med Bras (1992). 2021 Apr;67(4):555-560. doi: 10.1590/1806-9282.20201024. Rev Assoc Med Bras (1992). 2021. PMID: 34495060 Free article.

7

Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Wang W, Nag S, Zhang X, Wang MH, Wang H, Zhou J, Zhang R. Wang W, et al. Among authors: wang mh. Med Res Rev. 2015 Mar;35(2):225-85. doi: 10.1002/med.21327. Epub 2014 Aug 28. Med Res Rev. 2015. PMID: 25164622 Free PMC article. Review.

8

Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer.

Yao HP, Hudson R, Wang MH. Yao HP, et al. Among authors: wang mh. Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188425. doi: 10.1016/j.bbcan.2020.188425. Epub 2020 Sep 19. Biochim Biophys Acta Rev Cancer. 2020. PMID: 32961258 Free article. Review.

9

RON receptor tyrosine kinase in pancreatic ductal adenocarcinoma: Pathogenic mechanism in malignancy and pharmaceutical target for therapy.

Yao HP, Hudson R, Wang MH. Yao HP, et al. Among authors: wang mh. Biochim Biophys Acta Rev Cancer. 2020 Apr;1873(2):188360. doi: 10.1016/j.bbcan.2020.188360. Epub 2020 Mar 29. Biochim Biophys Acta Rev Cancer. 2020. PMID: 32234337 Free article. Review.

10

Antibody-drug conjugates targeting RON receptor tyrosine kinase as a novel strategy for treatment of triple-negative breast cancer.

Yao HP, Suthe SR, Hudson R, Wang MH. Yao HP, et al. Among authors: wang mh. Drug Discov Today. 2020 Jul;25(7):1160-1173. doi: 10.1016/j.drudis.2020.05.012. Epub 2020 May 29. Drug Discov Today. 2020. PMID: 32479905 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results